SNDX
Syndax Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.56
−0.58%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 46.20x
- P/S forward
- 5.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 121.59x
- Price / sales
- 7.29x
- Price / cash flow
- -8.32x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 7.45x
- EV / EBITDA
- -13.88x
- EV / EBIT
- -9.67x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026